Attributable testing for abnormal prion protein, database linkage, and blood-borne vCJD risks

Lancet

Volumn 364, Issue 9442, 2004, Pages 1362-1364

  Bird, Sheila M ^a  

^a MRC BIOSTATISTICS UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

AUTOPSY; BLOOD; BLOOD TRANSFUSION; BOVIDS; CREUTZFELDT JAKOB DISEASE; DATA BASE; DISEASE CARRIER; DISEASE TRANSMISSION; DONOR; FOLLOW UP; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH SURVEY; HUMAN; PLASMA; PRIORITY JOURNAL; RECIPIENT; RETICULOENDOTHELIAL SYSTEM; REVIEW; RISK; SURGICAL EQUIPMENT; SWITZERLAND; TONSIL; UNITED KINGDOM;

EID: 5044227384     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)17194-8     Document Type: Short Survey

References (29)

1. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 347:1996;921-925
2. Hill AF, Desbruslais M, Joiner S, Sidle KCL, Gowland I, Collinge J. The same prion strain causes vCJD and BSE. Nature. 389:1997;448-450
3. Hilton DA, Fathers E, Edwards P, Ironside JW, Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet. 352:1998;703-704
4. Ironside JW, Hilton DA, Ghani A, et al. Retrospective study of prion-protein accumulation in tonsil and appendix tissues. Lancet. 355:2000;1693-1694
5. Hilton DA, Ghani AC, Conyers L, et al. Accumulation of prion protein in tonsil and appendix: review of tissue samples. BMJ. 325:2002;633-634
6. Hilton DA, Ghani AC, Conyers L, et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol. 203:2004;733-739
7. Frosh A, Smith LC, Jackson CJ, et al. Analyses of 2000 consecutive UKtonsillectomy specimens for disease-related prion protein. Lancet. 364:2004;1260-1262
8. Llewelyn CA, Hewitt PE, Knight, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet. 363:2004;417-421
9. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet. 364:2004;527-529
10. Houston F, Foster JD, Chong A, Hunter N, Bostock CJ. Transmission of BSE by blood transfusion in sheep. Lancet. 356:2000;999-1000
11. Hunter N, Foster J, Chong A, et al. Transmission of prion diseases by blood transfusion. J Gen Virol. 83:2002;2897-2905
12. Wilesmith JW, Wells GAH, Ryan JBM, Gavier-Widen D, Simmons MM. A cohort study to examine maternally-associated risk factors for bovine spongiform encephalopathy. Vet Rec. 141:1997;239-243
13. Donnelly CA, Ferguson NM, Ghani AC, Anderson RM. Extending backcalculation to analyse BSE data. Stat Methods Med Res. 12:2003;177-190
14. Scientific Steering Committee. Opinion on BSE in United Kingdom's cattle born after 31 July 1996 (BARBs). Brussels: European Union, adopted April 10-11, 2003.
15. Gore SM. Bovine Creutzfeldt-Jakob disease? Failures of epidemiology need to be remedied. BMJ. 312:1996;791-792
16. Cooper JD, Bird SM. Predicting incidence of variant Creutzfeldt-Jakob disease from UK dietary exposure to bovine spongiform encephalopathy for the 1940 to 1969 and post-1969 birth cohorts. Int J Epidemiol. 32:2003;784-791
17. Herzog C, Sales N, Etchegaray N, et al. Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet. 363:2004;422-428
18. Ghani AC, Donnelly CA, Ferguson NM, Anderson RM.@ Updated projections of future vCJD deaths in the UK. BioMed Central Infect Dis 2003; 3: 4. http://www.biomedcentral.com/1471-2334/3/4 (accessed Aug 6, 2004).
19. Bird SM. Recipients of blood or blood products "at vCJD risk". We need to define their rights and responsibilities and those of others. BMJ. 328:2004;118-119
20. Doherr MG, Oesch B, Moser M, Vandevelde M, Heim D. Targeted surveillance for bovine spongiform encephalopathy. Vet Rec. 145:1999;672
21. Scientific Steering Committee. Opinion on requirements for statistically authoritative BSE/TSE surveys. Brussels: European Commission, Health Consumer Protection Directorate-General, November, 2001.
22. Bird SM. European Union's rapid TSE testing in adult cattle and sheep: implementation and results in 2001 and 2002. Stat Methods Med Res. 12:2003;261-278
23. Ferguson NM, Donnelly CA. Assessment of the risk posed by bovine spongiform encephalopathy in cattle in Great Britain and the impact of potential changes to current control measures. Proc R Soc Lond B Biol Sci. 270:2003;1579-1584
24. Arnold M, Wilesmith J. Modelling studies on BSE occurrence to assist in the review of the Over Thirty Months Rule in GB. Proc R Soc Lond B Biol Sci. 270:2003;2141-2145
25. Glatzel M, Ott PM, Linder T, et al. Human prion diseases: epidemiology and integrated risk assessment. Lancet Neurol. 2:2003;757-763
26. Health Protection Agency. Creutzfeldt-Jakob disease (CJD). Sept 21, 2004: http://www.hpa.org.uk/infections/topics_az/cjd/menu.htm (accessed Sept 27, 2004).
27. McDougall L. Blood patients plan their own postmortems: haemophiliacs fear vCJD will not be diagnosed. Sunday Herald Sept 5, 2004.
28. Fichet G, Comoy E, Duval C, et al. Novel methods for disinfection of prion-contaminated medical devices. Lancet. 364:2004;521-526
29. Kirkup B. Incident arising in October 2002 from a patient with Creutzfeldt-Jakob disease in Middlesbrough. Report of Incident Review. Feb 28, 2003: http://www.dh.gov.uk/PublicationsAndStatistics/Publications/ PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en? CONTENT_ID=4008283&chk=0q3nhw (accessed Aug 6, 2004).